These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2994121)

  • 1. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R; Vaccheri A; Montanaro N
    Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quipazine-induced head-twitch in mice.
    Malick JB; Doren E; Barnett A
    Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I; Minugh-Purvis N
    Brain Res; 1987 Sep; 420(2):403-6. PubMed ID: 2960422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin autoreceptor: antagonism by quipazine.
    Martin LL; Sanders-Bush E
    Neuropharmacology; 1982 May; 21(5):445-50. PubMed ID: 6981071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methiothepin on imipramine- or mianserin- induced subsensitivity of serotonergic receptors.
    Segawa T; Uehara M
    Life Sci; 1982 Mar; 30(10):809-12. PubMed ID: 7070196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 13. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J; Yanai J; Klawans HL; Chatterton R
    Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zotepine on head-twitch induced by L-5-hydroxytryptophan, mescaline and 2,5-dimethoxy-4-methylamphetamine in mice and rats.
    Yamamoto T; Tazoe N; Ueki S; Shimomura K; Satoh H; Mori J
    Jpn J Pharmacol; 1983 Apr; 33(2):319-25. PubMed ID: 6136619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats.
    Lucot JB; Seiden LS
    Pharmacol Biochem Behav; 1986 Mar; 24(3):537-41. PubMed ID: 3486425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo disposition of 3H-methiothepin in brain tissues. Relationship to the effects of acute treatment with methiothepin on central serotoninergic receptors.
    Nelson DL; Herbet A; Pichat L; Glowinski J; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Dec; 310(1):25-33. PubMed ID: 530311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram.
    Pawłowski L; Melzacka M
    Psychopharmacology (Berl); 1986; 88(3):279-84. PubMed ID: 3083448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of a model for central serotonin receptor activation.
    Matthews WD; Smith CD
    Life Sci; 1980 Apr; 26(17):1397-403. PubMed ID: 6247593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.